the Change of CEM and the Prognosis of Coronary Artery Disease in Real Clinical Practice

NCT03473860 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-03-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the change of total cholesterol content of erythrocyte membranes (CEM) in patients with coronary artery disease treated with secondary prevention drugs, and the correlation with the prognosis.

Conditions

Sponsors & Collaborators

  • First Affiliated Hospital of Jinan University

    collaborator OTHER
  • Lu'an Municipal Hospital

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03473860 on ClinicalTrials.gov